456
Views
17
CrossRef citations to date
0
Altmetric
Original

Moderators of Effects of Motivational Enhancements to Cognitive Behavioral Therapy

, Ph.D., , Ph.D., , Ph.D., , C.S.W. , Ph.D., , Ph.D. & , Ph.D.
Pages 35-58 | Published online: 07 Jul 2009
 

Abstract

Patient treatment matching hypotheses were tested for substance users randomly assigned to a group cognitive behavioral therapy (CBT; n = 114) or a group motivational intervention (GMI; n = 116). Treatment was scheduled twice weekly for 10 weeks. Using a patient attribute by treatment interaction design with a 15-week follow-up, the study predicted that alexithymia, antisocial personality disorder (ASPD), and network support for alcohol and drug use would be associated with less substance use for CBT subjects and that hostility and lower treatment motivation would be associated with less substance use for GMI subjects. Three of the hypothesized moderators were empirically supported: alexithymia, network support for alcohol, and ASPD. Results indicate the use of assessing specific patient attributes to better inform treatment recommendations.

Notes

aTherapy group membership evolved over time with new clients joining the group and other clients departing (e.g., upon completion of all sessions). Thus, there was not a specific group of peers with whom a given client experienced all treatment sessions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.